Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplant
- 1 October 1999
- journal article
- review article
- Published by Elsevier in Experimental Hematology
- Vol. 27 (10), 1477-1486
- https://doi.org/10.1016/s0301-472x(99)00096-x
Abstract
No abstract availableKeywords
This publication has 75 references indexed in Scilit:
- Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationThe Lancet, 1999
- Specific depletion of alloreactive T cells in HLA‐identical siblings: a method for separating graft‐versus‐host and graft‐versus‐leukaemia reactionsBritish Journal of Haematology, 1998
- Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donorsBone Marrow Transplantation, 1998
- Bone Marrow Transplants from Unrelated Donors for Patients with Chronic Myeloid LeukemiaNew England Journal of Medicine, 1998
- Chronic myeloid leukemiaCurrent Opinion in Hematology, 1998
- Peptides derived from the whole sequence of BCR‐ABL bind to several class I molecules allowing specific induction of human cytotoxic T lymphocytesEuropean Journal of Immunology, 1997
- Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic CellsScience, 1996
- SELECTIVE DEPLETION OF CD8+ CELLS FOR PREVENTION OF GRAFT-VERSUS-HOST DISEASE AFTER BONE MARROW TRANSPLANTATION A RANDOMIZED CONTROLLED TRIALTransplantation, 1994
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991
- T CELL SUBSETS AND GRAFT-VERSUS-HOST DISEASETransplantation, 1987